mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.02 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.02 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.02 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.03 |
mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.03 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.03 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.03 |